Century Therapeutics, Inc.
IPSC
$0.537
$0.0173.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.53% | -0.05% | -11.21% | 28.77% | -20.41% |
| Total Depreciation and Amortization | 0.61% | -4.74% | 7.32% | -9.18% | 6.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 443.33% | 570.00% | -108.26% | -70.99% | 253.77% |
| Change in Net Operating Assets | 147.96% | -354.70% | 107.88% | -210.75% | -123.90% |
| Cash from Operations | 14.50% | -3.66% | 9.64% | -15.32% | -92.18% |
| Capital Expenditure | -119.15% | 403.40% | 50.83% | 45.00% | 69.98% |
| Sale of Property, Plant, and Equipment | -200.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.79% | 259.95% | -298.60% | -38.31% | 161.73% |
| Cash from Investing | -21.92% | 215.75% | -393.42% | -37.96% | 341.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 71,722.12% | -71.58% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -231.50% | 217.42% | -- | -- |
| Cash from Financing | -320.51% | -99.52% | 211.61% | 5,210.96% | -218.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.11% | 347.61% | -778.71% | 93.59% | 12.58% |